Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Genprex, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 21 | 22 | +1 |
| Shares | 1.36M | 7.16K | −1.35M (−99.5%) |
| Value | $229.5K | $13.0K | −$216.5K (−94.3%) |
New holders (7)
Institutions that held Genprex, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cheviot Value Management, LLC | 1,000 | $2.22K | 0.00% |
| Miller Wealth Advisors, LLC | 1,200 | $2.10K | 0.00% |
| Jones Financial Companies LLLP | 1,055 | $1.85K | 0.00% |
| FMR LLC | 3 | $5 | 0.00% |
| Danske Bank A/S | 1 | $2 | 0.00% |
| Curio Wealth, LLC | 1 | $2 | 0.00% |
| Motiv8 Investments LLC | 1 | $0 | 0.00% |
Sold out (6)
Institutions that held Genprex, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Vanguard Group Inc | 433,369 | $73.2K |
| Susquehanna International Group, LLP | 340,056 | $57.6K |
| Jane Street Group, LLC | 205,180 | $34.8K |
| Geode Capital Management, LLC | 164,027 | $27.8K |
| TCG Advisory Services, LLC | 17,000 | $2.88K |
| Royal Bank of Canada | 63 | $0 |